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Abstract
Background: The emergence in recent years of numerous resistant strains of pathogenic bacteria to a range of
formerly efficient antibiotics constitutes a serious threat to public health. Crassocephalum bauchiense, a medicinal
herb found in the West Region of Cameroon is used to treat gastrointestinal infections as well as liver disorders.
The ethyl acetate extract from the leaves of C. bauchiense was evaluated for its antibacterial activity as well as
acute and sub-acute toxicities.
Methods: The plant extract was prepared by maceration in ethyl acetate. Its phytochemical screening was done
by standard methods. The broth microdilution method was used to evaluate the in vitro antibacterial activity. The
in vivo antibacterial activity of a gel formulation (0.05, 1 and 2% w/v) of this extract was evaluated using a
Staphylococcus aureus-induced dermatitis in a murine model. Selected haematological and biochemical parameters
were used to evaluate the dermal sub-acute toxicity of the extract in rats.
Results: Phytochemical screening of the C. bauchiense extract revealed the presence of alkaloids, phenols, tannins
and sterols. In vitro antibacterial activities were observed against all the tested microorganisms (MIC = 0.04-6.25
mg/ml). Formulated extract-gel (2% w/v) and gentamycin (reference drug) eradicated the microbial infection after
five days of treatment. A single dermal dose of this extract up to 32 g/kg body weight (bw) did not produce any
visible sign of toxicity. Also, daily dermal application of the C. bauchiense extract gel formulation for 28 days did
not show any negative effect, instead some biochemical parameters such as alanine aminotransferase (ALT and
AST), low density lipoprotein (LDL), high density lipoprotein (HDL) and triglycerides were significantly (p < 0.05)
affected positively.
Conclusion: These results indicate that the C. bauchiense ethyl acetate extract can be used safely for the treatment
of some bacterial infections.
Background
Plant-based medicaments had served from the onset as
the most important therapeutic weapon available for
man to fight various human and animal diseases. The
exclusive use of herbal remedies to treat and manage
ailments continued until the introduction of modern
synthetic medicines. The advent of synthetic medicines
in the health care system coupled with industrialization,
urbanization in most developed countries and the ten-
dency to embrace western culture by the developing
countries made the use of herbal products to decline
from about the beginning of the 20th century up to the
1970s [1]. However, in recent times, a renewed and
growing interest in the use of plant-derived biologically
active compounds as drugs or basis in the manufacture
of more potent medicaments has been noticed [2].
Plants therefore remain the main natural source of
active drugs and are still indispensable in traditional
medicine for the treatment of a large number of dis-
eases. Traditional medicines are used by about 60% of
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the world’s population both in the developing countries
and developed countries where modern medicines are
predominantly used [3].
In Cameroon, like in other developing countries, tradi-
tional medicine accounts for more than 80% of rural
populace health needs [4]. They are administered in
most of the disease conditions over a long period of
time without a proper dosage monitoring and considera-
tion of toxic effects that might result from such a pro-
longed use. Although, a great number of scientific
researchers demonstrated activities of several African
plants, few of them venture into studying their toxicity.
From field studies, Crassocephalum bauchiense
appears to be used in folk medicine in the West Region
of Cameroon to treat gastrointestinal infections as well
as liver disorders. To the best of our knowledge, no
scientific evaluation of the therapeutic potentials of this
plant has been done. The present work was designed to
ascertain the antibacterial activity and safety levels for
the dermal administration of ethyl acetate extract of




Crassocephalum bauchiense leaves were collected in
Dschang, West Region of Cameroon. The botanical
identification was done at the National Herbarium in
Yaoundé (Cameroon) by referring to the sample number
7954/SRF/Cam. A voucher specimen of the plant is kept
in the Herbarium of the Department of Plant Biology of
the University of Dschang under the code number
0033/UDs/PB.
Microorganisms
The microorganisms used included five ATCC bacterial
strains (Staphylococcus aureus ATCC 25922, Enterococ-
cus faecalis ATCC 10541, Escherichia coli ATCC 11775,
Pseudomonas aeruginosa ATCC 27853, Salmonella typhi
ATCC 6539) and three clinical isolates (Escherichia coli,
Pseudomonas aeruginosa, Staphylococcus aureus)
obtained from “Centre Pasteur du Cameroun, Yaoundé“.
The strains were maintained at +4°C on agar slants.
Experimental animals
Experiments were performed using Wistar albino adult
rats of both sex 10 to 12 weeks old (200 ± 30 g) and
female Swiss albino mice of 6 to 8 weeks old (18 ± 4 g)
bred in the animal house of the Department of Bio-
chemistry, University of Dschang, Cameroon. The ani-
mals were fed with a standard diet. Food and water
were given ad libitum to all animals used for the experi-
ments. Animals were maintained at room temperature
(22 ± 2°C) and were handled according to standard
protocols for the use of laboratory animals. The studies
were conducted according to the ethical guidelines of
Committee for Control and Supervision of Experiments
on Animals (Registration no. 173/CPCSEA, dated 28
January, 2000), Government of India, on the use of ani-
mals for scientific research.
Preparation of plant extract
The leaves of C. bauchiense were dried at room tem-
perature for ten days and powdered to coarse particles.
Seven hundred grams of the powder were macerated
with 5 l of ethyl acetate for two days with frequent stir-
ring. After filtration, the solvent was removed under
reduced pressure using a rotary evaporator (45°C) to
yield a paste of 71.75 g (10.25%). The phytochemical
analysis was performed following standard methods [5].
Preparation of the gel formulation of the extract
Shea butter oil was obtained from the seed of Shea nuts
collected from Bangwa, West region, Cameroon. Thirty
grams of the oil was thawed by heating in a boiling
water bath. Bee wax (7.5 g) (bought from a local honey
manufacturer) was added and homogenized to yield the
vehicle. Sufficient quantities of the ethyl acetate extract
of C. bauchiense were added to obtain extract-gel con-
centrations of 0.5, 1.0 and 2.0% w/v.
In vitro antibacterial activity
The in vitro antibacterial activity of the extract was per-
formed by determining the minimum inhibitory concen-
trations using broth microdilution method [6]. Briefly,
the stock solution of C. bauchiense extract was dissolved
in 5% tween 80 in water. Bacterial suspensions of about
1.5×108 CFU/ml (Mc Farland turbidity standard no. 0.5)
were prepared. To obtain the inocula, these suspensions
were diluted 100 times in Muller Hinton broth to give
1.5 × 106 CFU/ml. The antimicrobial susceptibility tests
were performed in 96 wells microplates. A serial two-
fold dilution of the plant extract was performed to
obtain final concentration range of 6.25 to 0.04 mg/ml
for the extract and from 128 to 0.0625 μg/ml for the
reference drugs in a total volume of 200 μl/well. Each
well contained the test substances at a particular con-
centration and the bacterial suspension (100 μl) in Mul-
ler Hinton broth. The plates were incubated at 35°C for
18 h. Growth was monitored colorimetrically using
iodotetrazolium chloride (INT). Viable bacteria change
the yellow dye of p-iodonitrotetrazolium violet to a pink
colour. All concentrations at which no visible colour
changes were observed were considered as inhibitory
concentrations and the lowest of these concentrations
was considered as the MIC. The bactericidal concentra-
tions were determined by adding 50 μl aliquots of the
preparations (without INT), which did not show any
visible colour change after incubation during MIC
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assays, into 150 μl of extract-free Mueller Hinton broth
[6]. These preparations were further incubated at 35°C
for 48 hrs and bacterial growth was revealed by the
addition of INT as above. All extract concentrations at
which no colour changes were observed were considered
as bactericidal concentrations. The smallest of these
concentrations was considered as the MBC [6].
The assays were carried out in triplicate. Gentamycin
and ciprofloxacin were used as positive controls, and 5%
tween 80 solution was used as negative control.
In vivo antimicrobial assay
Furs were clipped from about 10% of the body surface
area 24 h before the experiment. Infection was estab-
lished by inoculating the clipped portion, at two differ-
ent sites, with 0.1 ml of S. Aureus suspension (2 × 108
CFU/ml) prepared from an overnight culture [7].
Infected mice were divided into six groups of five ani-
mals each (three control and three test groups). The
first control group was not treated, the second and third
received vehicle and gentamycin (2%) respectively. The
three other groups were treated with gel-extract at 0.5,
1 and 2% (w/v) respectively. Treatment started 48 h
after the establishment of the infection by dermal appli-
cation of 0.05 g of gel-extract once per day for 5 conse-
cutive days. Body weights were measured before
inoculation of bacterial suspension and once daily dur-
ing the experiment period. At the end of the treatment,
animals were anaesthetised with chloroform vapour and
the skin sample was excised and homogenized in normal
saline and further cultured on Mannitol Salt Agar Med-
ium for bacterial count.
Acute toxicity study
A single dose dermal toxicity was conducted according
to the OECD guidelines of toxicity studies [8]. Furs
were clipped as described above prior to the application
of the test substance. Rats were divided into one control
and five treated groups (each group consisted of ten ani-
mals including 5 males and 5 females). The control
group received vehicle (32 g/kg) while each treated
group received the C. bauchiense extract gel at 4, 8, 16
and 32 g/kg bw by dermal application. Clinical signs
and mortality were observed 15, 30 min and 1, 2, 3 and
6 h after administration of test substances and twice
daily for 14 days. Body weights, water and food con-
sumption were recorded throughout the experimental
period.
Sub-acute toxicity study
Furs were clipped from at least 10% of the body surface
area of rats 24 h before the experiment [9]. Animals
were divided into one control and four treated groups.
Each group consisted of ten animals (5 females and
5 males). The control group received vehicle (2400 mg/kg)
and each treated group received the C. bauchiense extract-
gel (30 mg/kg, 300 mg/kg, 1200 mg/kg and 2400 mg/kg)
by dermal application for 28 days (once a day).
Observations were made twice each day for motility
and mortality. Clinical examinations were made once
prior to the first treatment and once weekly. Changes in
skin, fur, eyes, mucous membranes and excretions and
autonomic activity were noted [9]. At the end of the
21st days of exposure, motor activity, grip strength and
sensory reactivity to stimuli of different types were
assessed. Animal weight, water and food consumptions
were recorded throughout the experimental period.
Sample collection
On the 28th day of experiment, urine was collected from
individual metabolic cages containing animals subjected
to overnight fasting [10].
Blood samples were collected by cardiac puncture
from ketamine-diazepam anaesthetized rats into hepari-
nised and non heparinised tubes. The non heparinised
tubes were allowed to clot and were centrifuged at
3000 rpm for 5 min to obtain the serum. Animals were
further sacrificed and used for gross pathological exami-
nations including weight of different organs (liver, kid-
ney, lung, heart and spleen) [11]. Fifteen percent
homogenate of liver and spleen tissues from experimen-
tal animals were prepared in normal saline solution. The
homogenates obtained were centrifuged at 3.000 rpm for
30 min and the supernatants were used for protein
quantification [12].
Biochemical analysis
The serum was assayed for creatinine, aspartate amino
transferase (AST), alanine amino tranferase (ALT), total
cholesterol, high density lipoprotein (HDL), triglycerides
and total protein using commercial kits (Hospitex diag-
nostic, Roma, Italia). Urine was assayed for total protein
and creatinine using the same commercial kits. The
liver and spleen homogenates were also assayed for their
protein content.
Haematological analysis
Malassez chamber was used to quantify the total red
blood cells (RBCs) and white blood cells (WBCs). Hae-
matocrit was estimated using standard methods [13].
Histopathological analysis
Immediately after collecting the blood samples, vascular
perfusion was performed for hepatic tissue fixation
using isotonic saline solution (250 ml) followed by 10%
phosphate buffered formalin solution (250 ml). Small
pieces of liver were subjected to haematoxylin-eosin
staining [14]. Pathological observations were performed
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on gross and microscopic basis. Histological plates were
encrypted for analysis by a histopathologist.
Statistical analysis
Data were subjected to the one way analysis of variance
(ANOVA) and recorded as mean ± SD and where differ-
ences exist, means were compared using Waller Duncan
test at 0.05 significant level.
Results
Antibacterial activity
Phenols, alkaloids, flavonoids, tannins, triterpenes and
sterols were identified in the ethyl acetate extract of
C. bauchiense. This plant extract expressed antibacterial
activity on all the tested microorganisms (Table 1).
However, this activity was interesting only on S. aureus
(MIC = 48 μg/ml and MBC = 160 μg/ml). P. aeruginosa
and E. coli (clinical isolate) were the most resistant to the
extract (MIC = 3125 μg/ml and MBC = 6250 μg/ml).
MICs values were four fold less than the MBC values,
indicating that the bactericidal effect of the C. bauchiense
ethyl acetate extract could be expected.
Animals infected with S. aureus showed visible inflam-
mation 48 hours later, characterised by redness and
swelling of the skin at the sites of inoculation. Treat-
ment significantly (P < 0.05) reduced the bacterial con-
centration at the infection sites, with total suppression
being noted with the 1 and 2% doses of C. bauchiense
gel-extract as gentamycin in 5 days (Figure 1). Animals
in all groups showed weight loss after infection (Figure 2).
From day 1 of treatment, body weight increased gradually
with time. On the other hand, the weight gain by the ani-
mals of the negative control was lower than that of all the
other groups. However, the weight gain by the animals
that received the extract at 1 and 2% were comparable
(p > 0.05) to gentamycin group, and significantly higher
(p < 0.05) than the 0.5% extract-treated group.
Acute dermal toxicity
No significant variation was noted in rat’s body weight at
the end of 14 days of experiment between groups.
Besides, no changes in skin, fur, eyes, mucous mem-
branes, respiratory and behavioral pattern were observed.
In addition, no sign of convulsion, salivation, diarrhea,
lethargy, sleep were noted. Up to 32 g/kg bw in both
sexes, no death was observed, indicating that the lethal
dose fifty (LD50) of the C. bauchiense extract is higher
than 32 g/kg in rats.
Sub-acute toxicity
Effect of extract on relative organ weights
No deaths or signs of toxicity were observed at all doses in
the present study. Food and water intake did not show any
significant differences between the control and treated
groups and between treated groups in both sexes. Relative
weights of different vital organs (spleen, kidney, liver, lung
and heart) of treated groups were not significantly differ-
ent from that of control group in both sexes (Table 2).
Haematological and biochemical analysis
No significant changes were noted in RBCs, WBCs and
hematocrit for both treated male and female rats com-
pared to the control (Table 3). Also, no significant
Table 1 Antibacterial activity (MIC, MBC) of the ethyl









MIC 48 0.04 4
MBC 195 0.19 16
E. faecalis ATCC
10541
MIC 390 0.09 1
MBC 1562 1.56 1
E. coli
ATCC11775
MIC 1562 0.09 16
MBC 3125 1.56 32
P. aeruginosa
ATCC27853
MIC 1562 0.04 8
MBC 3125 0.19 16
S. typhi ATCC
6539
MIC 1562 0.19 2
MBC 3125 0.780 2
S. aureus MIC 781 8 0.25
MBC 1562 8 0.25
P. aeruginosa MIC 781 1 8
MBC 3125 16 8
E. coli MIC 3125 8 1
MBC 6250 8 1
Figure 1 Effect of the dose of gel-extract on weight gain as a
function of time.
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difference in urine and serum creatinine, spleen and
hepatic proteins were observed in both sexes. Besides,
ALT and AST levels significantly decreased in males
and female (Table 4). Lipid indices were affected
depending on the animal sex. Indeed, HDL was not
affected in female but increased significantly in males
from 30 mg/kg bw. In both sexes, the level of LDL and
Triglycerides decreased significantly. Total cholesterol
was not affected in both sexes. Histopathological analy-
sis showed no deleterious effects on the hepatic tissues
of the studied rats of either sex at all the tested doses.
Discussion
The C. bauchiense extract was found to express the
greatest antimicrobial activities on S. aureus, one of the
most common causes of skin infections [15]. About 20%
of the human population are long-term carriers of this
bacterial specie [16], responsible for skin infections like
impetigo, boils, cellulitis folliculitis, carbuncles, scalded
skin syndrome, and abscesses. It can also cause life-
threatening diseases such as pneumonia, meningitis,
osteomyelitis, endocarditis, toxic shock syndrome (TSS),
chest pain, bacteremia, and sepsis [17]. Since the 1 and 2%
gel-extracts completely eradicated the S. aureus-induced
dermatitis in rats within five days as gentamycin; it may be
used to treat the above mentioned diseases. The antimi-
crobial properties of this extract can be linked to the pre-
sence of alkaloids, phenols, tannins, triterpenes, flavonoids
and sterols. Indeed, members of these phytochemical
groups of compounds are known to possess antimicrobial
activities [18].
The LD50 of the extract was greater than 32 g/kg bw
and generally, in both acute and sub-acute toxicity stu-
dies, no adverse signs were detected in the treated rats.
Based on Hodge and Sterner scale, the C. bauchiense
extract could be considered as relatively harmless by
dermal route [19]. In addition, there were no treatment-
related changes in the haematological parameters
(hematocrit, RBC and WBC) compared to the control,
indicating that C. bauchiense extract gel was not toxic
to the circulating cells.
Organ-to-body weight ratio, an index often used in
toxicological evaluations [3], was not significantly altered
by sub-acute treatment. This lends credence to the
absence of injuries on the liver, lung, heart, spleen and
kidney. A significant decrease of ALT and AST was
noted in both sex. Liver damage and its recovery are
usually assessed by measuring the level of serum transa-
minases particularly ALT. Indeed changes in their
serum level are biological markers of liver dysfuntioning
and/or damage [20]. Thus, C. bauchiense extract may
not be hepatotoxic and may support the current use of
this plant species to control liver disorders by local
population from the West Region of Cameroon. These
results are confirmed by the absence of pathological
alteration on liver as reveal by histopathological studies.
Figure 2 Effect of gel-extract on bacterial load (UFC/ml) on the
5th day of treatment.
Table 2 Effect of dose and sex on organ relative weights of rats in sub-acute toxicity studies of the ethyl acetate
extract from C. bauchiense
Sex Relative organ weight (g/g of tissue)
Dose (mg/kg) liver kidney heart spleen lung
0 3.34 ± 0.22 0.85 ± 0.02 0.30 ± 0.01 0.39 ± 0.18 0.60 ± 0.09
Female 30 3.22 ± 0.37 0.88 ± 0.14 0.29 ± 0.08 0.35 ± 0.12 0.64 ± 0.12
300 3.18 ± 0.16 0.89 ± 0.07 0.27 ± 0.02 0.38 ± 0.05 0.72 ± 0.21
1200 3.16 ± 0.12 0.93 ± 0.03 0.28 ± 0.10 0.33 ± 0.04 0.63 ± 0.09
2400 3.17 ± 0.28 0.94 ± 0.06 0.29 ± 0.03 0.40 ± 0.12 0.73 ± 0.14
0 3.05 ± 0.22 0.81 ± 0.09 0.29 ± 0.03 0.32 ± 0.06 0.64 ± 0.08
30 2.85 ± 0.01 0.83 ± 0.07 0.28 ± 0.02 0.37 ± 0.02 0.68 ± 0.02
Male 300 3.05 ± 0.34 0.83 ± 0.09 0.26 ± 0.01 0.36 ± 0.02 0.69 ± 0.10
1200 3.07 ± 0.17 0.93 ± 0.29 0.27 ± 0.02 0.33 ± 0.04 0.69 ± 0.06
2400 2.96 ± 0.09 0.94 ± 0.03 0.27 ± 0.01 0.39 ± 0.09 0.69 ± 0.06
Data are expressed as Mean ± S.E.M. n = 5. Waller-Duncan test (P < 0.05).
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Similar results were reported with Crassocephalum vitel-
linum [21].
The degree to which elevated blood lipids contribute
to heart diseases is determined by their distribution
among the various lipoproteins classes. High cholesterol
level in the blood is the major cause of cardiovascular
disorders [22]. High serum levels of triglycerides and
low density lipoproteins are associated with coronary
artery disease [23]. We noticed a reduction in the serum
levels of triglycerides and low density lipoproteins in
Table 3 Haematological parameters of rats in sub-acute toxicity of the ethyl acetate extract from Crassocephalum
bauchiense
parameter Control 30 mg/kg 300 mg/kg 1200 mg/kg 2400 mg/kg
Female
RBC (106 mm-3) 9.13 ± 0.30 10.00 ± 0.34 10.46 ± 0.34 10.52 ± 0.32 10. 53 ± 0.37
WBC (103 mm-3) 4.74 ± 0.41 4.80 ± 0.42 4.95 ± 0.32 5.01 ± 0.41 5.30 ± 0.46
PCV (%) 32.25 ± 3.93 32.80 ± 5.30 36.20 ± 4.14 33.40 ± 3.43 33.20 ± 7.39
Male
RBC (106 mm-3) 9.89 ± 0.63 11.10 ± 0.48 11.83 ± 1.01 11.45 ± 1.32 11.92 ± 0.66
WBC (103 mm-3) 5.38 ± 0.56 5.51 ± 0.32 5.6 ± 0.59 6.34 ± 1.34 6.38 ± 0.94
PCV (%) 36.80 ± 3.83 37.00 ± 2.16 37.40 ± 7.16 38.60 ± 7.70 39.00 ± 6.82
Data are expressed as mean ± S.E.M., n = 5, RBC = Red blood cell, WBC, = White blood cell PCV = packed cell volume (%).
Table 4 Biochemical parameters of rats in sub-acute toxicity of the ethyl acetate extract from Crassocephalum
bauchiense as a function of treatment dose
Dosage (mg/kg) 0 30 300 1200 2400
Female
TCHL 79.90 ± 7.56a 82.02 ± 7.04a 77.10 ± 5.59a 82.89 ± 6.64a 77.35 ± 5.36a
HDL 52.66 ± 3.28a 54.95 ± 2.15a 52.37 ± 4.34a 52.40 ± 5.40a 51.75 ± 3.40a
LDL 9.00 ± 0.82a 10.02 ± 0.71a 10.10 ± 1.47a 3.75 ± 1.50b 0.39 ± 0.05c
TG 238.45 ± 7.84a 128.69 ± 8.046b 125.24 ± 8.22b 125.35 ± 7.52b 129.31 ± 0.65b
UC 79.90 ± 2.33a 83.11 ± 2.33a 81.51 ± 4.06a 84.09 ± 4.24a 85.25 ± 4.84a
SC 0.84 ± 0.04a 0.83 ± 0.02a 0.85 ± 0.04a 0.85 ± 0.04a 0.82 ± 0.02a
SP 19.30 ± 2.26a 19.99 ± 1.74a 21.02 ± 1.61a 22.12 ± 1.83a 21.26 ± 1.93a
UP 2.67 ± 0.52a 2.80 ± 0.50a 2.69 ± 0.46a 2.16 ± 0.37b 2.27 ± 0.49b
SPL 27.25 ± 1.85a 25.85 ± 2.43a 27.61 ± 1.78a 26.25 ± 1.93a 27.48 ± 1.95a
HP 33.18 ± 6.68a 26.66 ± 4.91a 28.88 ± 6.12a 30.69 ± 6.57a 28.92 ± 3.35a
ALT 12.52 ± 0.85a 10.20 ± 1.65b 7.07 ± 2.28c 6.50 ± 2.13c 6.68 ± 2.87c
AST 55.74 ± 2.61a 55.83 ± 2.32a 52.57 ± 5.84a 40.90 ± 1.02b 39.60 ± 1.24b
Male
TCHL 116.76 ± 9.97a 119.22 ± 13.21a 113.04 ± 9.05a 117.77 ± 9.04a 117.07 ± 10.73a
HDL 27.92 ± 2.90c 51.28 ± 3.52b 51.40 ± 2.09b 55.44 ± 1.83a,b 57.67 ± 4.88a
LDL 8.60 ± 0.54a 10.34 ± 0.46b 1.96 ± 0.07c 1.20 ± 0.44d 0.41 ± 0.12e
TG 157.96 ± 6.85a 118.81 ± 7.81c 133.95 ± 7.18b 128.31 ± 5.91b 125.22 ± 7.38b
UC 85.00 ± 2.89a 82.68 ± 4.13a 82.62 ± 2.14a 82.14 ± 3.77a 85.53 ± 3.67a
SC 0.80 ± 0.05a 0.84 ± 0.01a 0.80 ± 0.01a 0.80 ± 0.05a 0.84 ± 0.04a
SP 23.33 ± 4.94a 23.14 ± 3.98a 23.61 ± 5.06a 24.04 ± 3.34a 23.25 ± 1.92a
UP 0.86 ± 0.06a 0.82 ± 0.11a 0.90 ± 0.15a 0.70 ± 0.16b 0.70 ± 0.10b
SPL 3.62 ± 0.77a 3.64 ± 0.73a 3.45 ± 0.36a 3.60 ± 0.49a 3.48 ± 0.29a
HP 29.63 ± 1.29a 29.87 ± 1.66a 27.42 ± 1.67a 28.35 ± 2.03a 29.72 ± 2.34a
ALT 14.81 ± 3.00a 10.10 ± 1.43b 9.24 ± 1.73b,c 7.43 ± 0.58c,d 5.03 ± 1.17d
AST 54.93 ± 3.04a 53.24 ± 5.26a 56.16 ± 3.43a 38.37 ± 3.39b 35.63 ± 2.54b
Data are expressed as mean ± S.E.M. n = 5. TCHL = total cholesterol (mg/dl); HDL = high density lipoprotein (mg/dl); LDL = low density lipoprotein (mg/dl); TG =
triglycerides(mg/dl); UC = urine creatinine(mg/dl); SC = serum creatinine(mg/dl); SP = serum protein(mg/ml); UP = urine protein(μg/ml); SPL = spleen protein (mg/g);
HP = hepatic protein(mg/g); ALT = alanine transaminase(U/L); AST = Aspartate transaminase(U/L).
Values for a given group in a line followed by same letter as superscript are not significantly different according to Waller Dunkan multiple comparison
procedure (at P < 0.05).
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animals treated with C. bauchiense gel-extract. This sug-
gests that the plant extract may contain hypolipidaemic
properties and thus might be interesting in the preven-
tion of cardiovascular diseases development.
The significant increase in the serum level HDL cho-
lesterol further strengthens the fact that the plant
extract may be used to reduce the risk factors of cardio-
vascular diseases. For it is established HDL may exert a
protective effect against arteriosclerosis and may pro-
mote the mobilization of cholesterol, thereby reducing
its deposition in vessel walls [23]. HDL is known to
offer some removal mechanism that gets rid of periph-
eral tissue cholesterol as well as cholesterol from VLDL
and LDL.
Conclusion
The overall results of this study indicate that the C.
bauchiense ethyl acetate extract can be used safely for
the treatment of bacterial infections. Further purification
and characterization of the active principles of the
extract would provide a better understanding of the
antimicrobial mechanism.
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